(Q38087428)

28 August 2017

title

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). (English)

1 reference

28 August 2017

1 reference

1 reference

poliovirus

1 reference

4

Cara C Burns

1 reference

28 August 2017

2

Mark A Pallansch

1 reference

Radboud J Duintjer Tebbens

28 August 2017

series ordinal

1

object named as

Radboud J Duintjer Tebbens

1 reference

28 August 2017

6

M Steven Oberste

1 reference

28 August 2017

9

Stephen L Cochi

1 reference

28 August 2017

8

Steven G F Wassilak

1 reference

28 August 2017

5

Olen M Kew

1 reference

28 August 2017

10

Kimberly M Thompson

1 reference

28 August 2017

7

Ousmane M Diop

1 reference

28 August 2017

Jong-Hoon Kim

3

1 reference

28 August 2017

publication date

7 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

680-702

1 reference

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Modeling population immunity to support efforts to end the transmission of live polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Expert review on poliovirus immunity and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Estimating the extent of vaccine-derived poliovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Reaching the last one per cent: progress and challenges in global polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Vaccination against polio should not be stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Circulating vaccine derived polio viruses and their impact on global polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Recombinant vaccine-derived poliovirus in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

From emergence to eradication: the epidemiology of poliomyelitis deconstructed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Relation of poliomyelitis virus types to clinical disease and geographic distribution: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Vaccine-Associated Paralytic Poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in toyama prefecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Long-term excretion of vaccine-derived poliovirus by a healthy child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRISA.12022

A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating

21 January 2018

1 reference

12 December 2020

The molecular biology of poliovaccines

1 reference

12 December 2020

Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus

1 reference

12 December 2020

Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases

1 reference

12 December 2020

Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines

1 reference

12 December 2020

Identification of two determinants that attenuate vaccine-related type 2 poliovirus

1 reference

12 December 2020

Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2

1 reference

12 December 2020

Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature

1 reference

12 December 2020

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype

1 reference

12 December 2020

Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine

1 reference

12 December 2020

Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine

1 reference

12 December 2020

Genetic analysis of the attenuation phenotype of poliovirus type 1.

1 reference

12 December 2020

Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984

1 reference

12 December 2020

The excretion of type 1 poliovirus after challenge following primary immunization with quadruple, Salk and Sabin vaccines

1 reference

12 December 2020

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter

1 reference

12 December 2020

WHO Expert Committee on Biological Standardization. Thirty-third report

1 reference

12 December 2020

Some observations on poliomyelitis lameness surveys.

1 reference

12 December 2020

Experiences associated with the use of live poliovirus vaccine in Hungary, 1959-1982.

1 reference

12 December 2020

The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group

1 reference

12 December 2020

Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus

1 reference

12 December 2020

Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus

1 reference

12 December 2020

Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil

1 reference

12 December 2020

Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine

1 reference

12 December 2020

Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses

1 reference

12 December 2020

Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis

1 reference

12 December 2020

Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.

1 reference

12 December 2020

Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence

1 reference

12 December 2020

Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates

1 reference

12 December 2020

A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

1 reference

12 December 2020

Limited genetic changes in the Sabin 1 strain of poliovirus occurring in the central nervous system of monkeys

1 reference

12 December 2020

Basic concepts in RNA virus evolution

1 reference

12 December 2020

Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients

1 reference

12 December 2020

Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil

1 reference

12 December 2020

Surveillance for polio eradication in the People's Republic of China

1 reference

12 December 2020

Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman

1 reference

12 December 2020

Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis

1 reference

12 December 2020

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

1 reference

12 December 2020

Progress towards global poliomyelitis eradication. The approaching extinction of wild poliovirus type 2

1 reference

12 December 2020

Transmission of wild poliovirus type 2--apparent global interruption

1 reference

12 December 2020

Prevalence of vaccine-derived polioviruses in the environment

1 reference

12 December 2020

Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.

1 reference

12 December 2020

Requirements for persistent immunity to poliomyelitis

1 reference

12 December 2020

Possible protective effect of previous type 2 infection against paralytic poliomyelitis due to type 1 virus

1 reference

12 December 2020

Vaccination against poliomyelitis with live virus vaccines. 6. Changes in Sabin type II oral vaccine virus after human passage

1 reference

12 December 2020

A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.

1 reference

12 December 2020

Circulating vaccine-derived polioviruses: current state of knowledge

1 reference

12 December 2020

Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003-June 2004

1 reference

12 December 2020

Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004

1 reference

12 December 2020

Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003-June 2004

1 reference

12 December 2020

Molecular mechanisms of poliovirus variation and evolution.

1 reference

12 December 2020

Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines

1 reference

12 December 2020

Vaccine-derived polioviruses

1 reference

12 December 2020

Update on vaccine-derived polioviruses.

1 reference

12 December 2020

Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007.

1 reference

12 December 2020

The risks, costs, and benefits of possible future global policies for managing polioviruses

1 reference

12 December 2020

The case for cooperation in managing and maintaining the end of poliomyelitis: stockpile needs and coordinated OPV cessation.

1 reference

12 December 2020

Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota

1 reference

12 December 2020

Update on vaccine-derived polioviruses--worldwide, January 2008-June 2009.

1 reference

12 December 2020

Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.

1 reference

12 December 2020

Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence

1 reference

12 December 2020

[Analysis of genetic characteristics of type II non-wild poliovirus in mainland China, 2010].

1 reference

12 December 2020

Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.

1 reference

12 December 2020

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1111/RISA.12022

1 reference

28 August 2017

1 reference